Drug Price Regulator Issues Notice To 21 Hospitals Over Knee Implant Prices
Drug pricing regulator NPPA has sought explanation from 21 hospitals for not displaying on their websites prices of knee implant systems at which they are billing patients.
The hospitals, in Rajasthan and Gujarat, have been given seven days to respond and explain reasons for not adhering to the government's directives.
In a notice to the hospitals, the National Pharmaceutical Pricing Authority said the websites of hospitals did not display MRP or price of knee implant systems at which they were billing patients, along with brand name, specifications and names of manufacturing or marketing company.
The list includes five hospitals in Jodhpur, six in Udaipur, three each in Bikaner and Nagaur in Rajasthan. It also includes four hospitals in Ahmedabad.
Also Read: Forty Hospitals To Face NPPA Action For Not Displaying Knee Implant Rates
As per a notification on August 16, 2017 and a subsequent office memorandum, the NPPA said hospitals, nursing homes and clinics were required to display on the homepage of their websites the MRP or price of knee implant systems at which they were billing patients.
Besides cardiac stents, the government had fixed a price range for knee implants from Rs 54,000 to Rs 1.14 lakh, nearly 70 percent lower than their earlier price.
With private hospitals reportedly charging exorbitant rates, the government said the move to cap the maximum retail price of the keen implants will save patients an estimated Rs 1,500 crore annually.
Also Read: Knee Implant Price Cap: Firms Asked To Maintain Supplies
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.